Ensysce Biosciences files 8-K/A
- Includes audited financials of Cy Biopharma for 2025 and 2024
- Unaudited financials for six months ended June 30, 2026
- Pro forma financials for 2026 and 2025 included
Every EDGAR filing for Ensysce Biosciences, Inc. (ENSCW), newest first, with AI summaries and stories.
Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.
Ownership stake disclosure by Bob G Gower (amended)
Bob G Gower, filed by
Bob G Gower, insider filing for ENSCW
Bob G Gower, reporting
James William Morrison, new insider at ENSCW
James William Morrison, reporting